This finding stresses the need to reduce the risk of sexual transmission of hep C among HIV-positive men who have sex with men.

Researchers conducted a systematic review and meta-analysis to estimate the rate of spontaneous loss of surface antigen in those with hep B.

This finding follows a recent study indicating that syphilis is on the rise among heterosexual people who inject drugs.

A recent study tested the effectiveness and tolerability of Technivie (ombitasvir/paritaprevir/ritonavir) among those over 65.

Researchers determined what proportion of those who tested positive made it through each of nine key steps on the way to being cured.

A placebo-controlled study of obeticholic acid showed it improved liver fibrosis with no worsening of non-alcoholic steatohepatitis.

Researchers found that free testosterone levels were low even after successful treatment for hep C.

The placebo-controlled trial Phase III trial of selonsertib had sought to improve fibrosis while not worsening NASH.

Plans have increasingly instituted preauthorization requirements for the opioid medication-assisted treatment buprenorphine.

Transplantees can be treated safely and effectively for hep C, so greater education regarding such methods is in order.